Compare ELTK & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTK | HYFT |
|---|---|---|
| Founded | 1970 | 1983 |
| Country | Israel | United States |
| Employees | N/A | 102 |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3M | 55.1M |
| IPO Year | 1998 | N/A |
| Metric | ELTK | HYFT |
|---|---|---|
| Price | $8.31 | $1.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 3.7K | ★ 202.9K |
| Earning Date | 05-19-2026 | 03-12-2026 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.18 | N/A |
| Revenue Next Year | N/A | $29.18 |
| P/E Ratio | $48.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.73 | $0.99 |
| 52 Week High | $12.19 | $3.00 |
| Indicator | ELTK | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 55.32 |
| Support Level | $7.79 | $1.02 |
| Resistance Level | $9.34 | $1.31 |
| Average True Range (ATR) | 0.37 | 0.11 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 54.89 | 58.51 |
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.